On June 16, GEROPHARM and the Government of Saint Petersburg at SPIEF-2023 signed a cooperation agreement to implement the investment project aimed at expanding the manufacture of medicinal products and increasing their export potential.
Market participants were significantly less active in early 2023 than during the rush demand in the spring of 2022. However, both inflation rates and stable household incomes now allow us to make optimistic industry growth forecasts, at least in the short term.
On June 8, at the Eurasia – Our Home exhibition, GEROPHARM and Karaganda Pharmaceutical Plant signed a long-term contract to localize the production of...
JSC “Pharmstandard” informs about the change to the membership of the Company's management and the appointment of Dmitry Ivanovich Zaytsev as Chief Executive Officer.
Potapov...
The Ministry of Health of the Russian Federation has authorized the first Russian originator for the treatment of multiple sclerosis developed by the scientists of...